Scientific paper

Thu. 31 March

Development of small macrocyclic kinase inhibitors

Share on

Development of small macrocyclic kinase inhibitors

Authors:
Ma J, Sanchez-Duffhues G, Caradec J, Benderitter P, Hoflack J, Dijke PT.

Abstract:
No abstract available.

Ref:
Future Med Chem. 2022 Mar; 14(6):389-391. doi: 10.4155/fmc-2021-0342. Epub 2022 Jan 14. PMID: 35029506

Read the paper here

Read the others news

OPM obtains €5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101

Financial

News

Press Release

Wed. 17 April

OPM obtains €5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101

Read more

OPM publishes its annual results for 2023 and provides an update on its clinical developments

Financial

News

Press Release

Tue. 26 March

OPM publishes its annual results for 2023 and provides an update on its clinical developments

Read more

Oncodesign Precision Medicine obtains Deep TechDevelopment funding for its ANIMUS program

Financial

News

Press Release

Thu. 29 February

Oncodesign Precision Medicine obtains Deep TechDevelopment funding for its ANIMUS program

Read more

Read all news